These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


234 related items for PubMed ID: 22879978

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Combined Fc-protein- and Fc-glyco-engineering of scFv-Fc fusion proteins synergistically enhances CD16a binding but does not further enhance NK-cell mediated ADCC.
    Repp R, Kellner C, Muskulus A, Staudinger M, Nodehi SM, Glorius P, Akramiene D, Dechant M, Fey GH, van Berkel PH, van de Winkel JG, Parren PW, Valerius T, Gramatzki M, Peipp M.
    J Immunol Methods; 2011 Oct 28; 373(1-2):67-78. PubMed ID: 21855548
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. scFv-based "Grababody" as a general strategy to improve recruitment of immune effector cells to antibody-targeted tumors.
    Cai Z, Fu T, Nagai Y, Lam L, Yee M, Zhu Z, Zhang H.
    Cancer Res; 2013 Apr 15; 73(8):2619-27. PubMed ID: 23396586
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Novel conjugates of single-chain Fv antibody fragments specific for stem cell antigen CD123 mediate potent death of acute myeloid leukaemia cells.
    Stein C, Kellner C, Kügler M, Reiff N, Mentz K, Schwenkert M, Stockmeyer B, Mackensen A, Fey GH.
    Br J Haematol; 2010 Mar 15; 148(6):879-89. PubMed ID: 20064159
    [Abstract] [Full Text] [Related]

  • 7. Effective elimination of acute myeloid leukemic cells by recombinant bispecific antibody derivatives directed against CD33 and CD16.
    Singer H, Kellner C, Lanig H, Aigner M, Stockmeyer B, Oduncu F, Schwemmlein M, Stein C, Mentz K, Mackensen A, Fey GH.
    J Immunother; 2010 Mar 15; 33(6):599-608. PubMed ID: 20551837
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antibody dependent cell-mediated cytotoxicity induced by chimeric mouse-human IgG subclasses and IgG3 antibodies with altered hinge region.
    Michaelsen TE, Aase A, Norderhaug L, Sandlie I.
    Mol Immunol; 1992 Mar 15; 29(3):319-26. PubMed ID: 1557042
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Correlation between CD16a binding and immuno effector functionality of an antigen specific immunoglobulin Fc fragment (Fcab).
    Kainer M, Antes B, Wiederkum S, Wozniak-Knopp G, Bauer A, Rüker F, Woisetschläger M.
    Arch Biochem Biophys; 2012 Oct 15; 526(2):154-8. PubMed ID: 22634259
    [Abstract] [Full Text] [Related]

  • 15. CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia.
    Hosen N, Park CY, Tatsumi N, Oji Y, Sugiyama H, Gramatzki M, Krensky AM, Weissman IL.
    Proc Natl Acad Sci U S A; 2007 Jun 26; 104(26):11008-13. PubMed ID: 17576927
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Regulation of antibody-dependent cellular cytotoxicity by IgG intrinsic and apparent affinity for target antigen.
    Tang Y, Lou J, Alpaugh RK, Robinson MK, Marks JD, Weiner LM.
    J Immunol; 2007 Sep 01; 179(5):2815-23. PubMed ID: 17709495
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.